10 February 2014 - Deborah Wilkes
Archived
Chile's CFR Pharmaceuticals has abandoned its planned takeover of South Africa's Adcock Ingram, after a consortium led by Bidvest acquired a 34.5% stake in Adcock Ingram.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.